MabVax Therapeutics Garners $3,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c237cddd-b07a-4941-bd51-a22f4c26f584
Date
7/9/2014
Company Name
MabVax Therapeutics
Mailing Address
11588 Sorrento Valley Road San Diego, CA 92121 USA
Company Description
MabVax Therapeutics, Inc. is a San Diego, California based immunotherapeutics discovery and development company focused on developing and commercializing novel vaccines and human antibodies for the treatment of cancer.
Website
http://www.mabvax.com
Transaction Type
Venture Equity
Transaction Amount
$3,000,000
Transaction Round
Undisclosed
Proceeds Purposes
These follow-up transactions prior to the anticipated merger with Telik will help us continue to finance our lead monoclonal antibody product, 5B1, and our clinical stage cancer vaccine programs. We hope to see several of our programs achieve significant milestones in the next 24 to 30 months.
M&A Terms
Venture Investor